INR

INR
Name	International Normalized Ratio
Caption	Prothrombin time test components
Test	Prothrombin time-derived standardized ratio
Purpose	Monitor oral anticoagulation with vitamin K antagonists
Specimen	Plasma (citrated)
Normal range	Variable; see target ranges

INR

Introduction

The International Normalized Ratio standardizes prothrombin time results for patients receiving vitamin K antagonist therapy and is central to monitoring anticoagulation in settings such as World Health Organization–guided public health programs, National Institutes of Health–funded clinical trials, and practice guidelines produced by organizations like the American College of Cardiology and the European Society of Cardiology. Developed to harmonize assays across laboratories that used reagents from manufacturers such as Beckman Coulter, Siemens Healthineers, and Stago, the ratio facilitates comparison of results obtained in centers including Mayo Clinic, Cleveland Clinic, and university hospitals like Johns Hopkins Hospital and Massachusetts General Hospital. It is used in patient management alongside diagnostic modalities found in centers such as Mount Sinai Health System and UCLA Health.

Medical Use and Clinical Significance

Clinicians at institutions including Royal College of Physicians, American Heart Association, and British Society for Haematology rely on the standardized value to guide treatment for indications described in guidelines from American College of Chest Physicians and trials such as those conducted by European Medicines Agency collaborators. Common indications include prevention of thromboembolism in prosthetic valve recipients from centers like Cleveland Clinic, management after venous thromboembolism treated in cohorts at Mayo Clinic, and stroke prevention in patients evaluated in registries such as the Get With The Guidelines program from American Heart Association. The standardized ratio also informs perioperative planning referenced in protocols at institutions like Royal Infirmary of Edinburgh and anticoagulation clinics in systems such as NHS England.

Measurement and Calculation

Laboratories affiliated with networks such as College of American Pathologists and Clinical and Laboratory Standards Institute perform prothrombin time testing using thromboplastin reagents traceable to standards from organizations like International Standards Organization and calibrators from manufacturers such as Werfen and Siemens. The standardized ratio is calculated using the patient prothrombin time, a mean normal prothrombin time established by individual laboratories, and an International Sensitivity Index assigned to each thromboplastin lot, a process overseen historically by groups including the World Health Organization and researchers at University of Oxford and Imperial College London. Reference laboratories at institutions such as Centers for Disease Control and Prevention have validated methodologies used in multicenter studies sponsored by entities like the National Heart, Lung, and Blood Institute.

Target Ranges and Interpretation

Target ranges recommended by guideline bodies including American College of Chest Physicians, European Society of Cardiology, and national formularies such as National Institute for Health and Care Excellence vary by indication: mechanical prosthetic valves as per evidence from trials conducted at Duke University Hospital and St Thomas' Hospital, certain antiphospholipid syndrome cases informed by cohorts from Mayo Clinic, and atrial fibrillation management based on meta-analyses led by researchers at Harvard Medical School. Clinical decision-making references consensus statements from organizations like International Society on Thrombosis and Haemostasis and registries such as National Cardiovascular Data Registry to balance thrombotic risk against bleeding risk assessed with tools validated at institutions including Brigham and Women's Hospital.

Factors Affecting INR=

Multiple factors documented in studies from centers such as Karolinska Institute, University of Toronto, and Monash University alter the standardized ratio: interacting medications studied in trials conducted by pharmaceutical regulators like European Medicines Agency and U.S. Food and Drug Administration, dietary vitamin K variability noted in cohorts at University of California, San Francisco and University of Sydney, and comorbid conditions reported in case series from Stanford Health Care and Cedars-Sinai Medical Center. Interferences with assay reagents have been characterized by manufacturers including Siemens Healthineers and academic laboratories at University College London, while genetic polymorphisms affecting metabolism were described in work from University of Cambridge and University of Chicago.

Management and Anticoagulation Therapy Adjustments

Clinical protocols from institutions such as Mayo Clinic, Cleveland Clinic, and national guidelines from American College of Cardiology and European Society of Cardiology outline dose adjustments of vitamin K antagonists based on the standardized ratio, bridging strategies referencing practices at Massachusetts General Hospital and reversal approaches influenced by products approved by U.S. Food and Drug Administration and European Medicines Agency. Anticoagulation clinics operating within networks like Kaiser Permanente and trials led by groups at University of Oxford have compared monitoring frequency and point-of-care testing devices marketed by companies such as Roche Diagnostics and Abbott Laboratories.

History and Development of the INR System

The international standardization effort emerged from collaborations among experts at World Health Organization, reagent manufacturers such as Woelm Biochemica and Organon Teknika, and academic laboratories at University of London and University of Edinburgh. Seminal publications from research groups at University of Manchester and Karolinska Institute formalized the use of an International Sensitivity Index to correct for thromboplastin variability, a process that facilitated multinational clinical trials coordinated by organizations including National Institutes of Health and European Commission research programs. Subsequent refinements and adoption in guidelines by bodies like British Committee for Standards in Haematology and American College of Chest Physicians extended its implementation across healthcare systems worldwide.

Category:Laboratory tests